Tracking and implementation of label changes stand crucial to the lifecycle of a marketed drug product. With the dynamic nature of safety data changes, what best practices manufacturers should adopt for end-to-end label tracking? Here is Freyr’s opinion published in the PharmTech.

Click here to read the complete Issue in the "PharmTech".